Banks Jerel A. 4
4 · Benitec Biopharma Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Banks Jerel A.
DirectorChief Executive Officer
Transactions
- Award
Options (right to buy)
2023-06-13+356,900→ 356,900 totalExercise: $0.23Exp: 2033-06-13→ Common Stock (356,900 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026.